Kratom Payment Processing for Legal Kratom Retailers

Kratom (Mitragyna speciosa) is a botanical product sold legally in the majority of US states, but its regulatory situation at the federal level creates the uncertainty that causes acquiring banks to decline kratom payment processing applications as a matter of policy. The FDA has issued warning letters to specific companies making unsubstantiated health claims about kratom, but has not scheduled it or prohibited its general sale. The DEA attempted to place kratom in Schedule I in 2016 but withdrew the proposal following significant public and legislative response.

Visa and Mastercard card network rules give acquiring banks broad discretion over which product categories they will support. Most domestic acquiring banks have used that discretion to exclude kratom payment processing from their merchant portfolios, which means processors without specific banking relationships approved for the category cannot underwrite kratom retailers regardless of their compliance record.

The practical result is that kratom payment processing accounts opened through mainstream platforms do not last. Transaction monitoring systems identify the product category and flag the account for review. Retailers who have been through this cycle need a kratom payment processing account structured from the beginning through an acquiring bank that has assessed and accepted the category, not one that will terminate the account when its monitoring system catches up.